Abstract
The polymerase chain reaction (PCR) was used to detect malignant lymphoma cells with the bcl-2 gene rearrangement in the peritoneal washings and bone marrow of a patient with an apparently localised gastric lymphoma. After four courses of cytotoxic drug treatment the cells could no longer be detected in either site. PCR is a useful addition to the staging investigations of non-Hodgkin lymphoma and can also be used to monitor response to treatment.
MeSH terms
-
B-Lymphocytes
-
Bone Marrow Examination
-
Chromosome Mapping
-
DNA, Neoplasm / analysis
-
DNA-Directed DNA Polymerase*
-
Drug Evaluation
-
Humans
-
Lymphoma, Non-Hodgkin / genetics
-
Lymphoma, Non-Hodgkin / pathology*
-
Male
-
Middle Aged
-
Neoplasm Staging
-
Oligonucleotide Probes
-
Peritoneal Lavage
-
Proto-Oncogene Proteins / analysis
-
Stomach Neoplasms / genetics
-
Stomach Neoplasms / pathology*
-
Translocation, Genetic
Substances
-
DNA, Neoplasm
-
Oligonucleotide Probes
-
Proto-Oncogene Proteins
-
DNA-Directed DNA Polymerase